Israel - English - Ministry of Health

teva israel ltd - atropine sulfate - solution for injection - atropine sulfate 20 mg / 10 ml - atropine - atropine - preanesthetic medication to decrease excessive salivation and secretions of the respiratory tract. treatment of sinus bradycardia, particularly if complicated by hypotension. antidote in poisoning by organophosphorus.

Israel - English - Ministry of Health

teva israel ltd - modafinil - caplets - modafinil 100 mg - modafinil - modafinil - to improve wakefulness in patients with excessive sleepiness associated with narcolepsy (with or without cataplexy), obstructive sleep apnea/hypopnea syndrome ( osahs ) and shift work sleep disorder (swds).

Israel - English - Ministry of Health

cts chemical industries ltd, israel - carbocisteine - capsules - carbocisteine 375 mg - carbocisteine - carbocisteine - treatment of disorders of the respiratory tract characterised by excessive or viscous mucus.

Israel - English - Ministry of Health

cts chemical industries ltd, israel - carbocisteine - drops - carbocisteine 75 mg/ml - carbocisteine - carbocisteine - treatment of disorders of the respiratory tract characterized by excessive or viscous mucus.

Israel - English - Ministry of Health

cts chemical industries ltd, israel - carbocisteine - lozenges - carbocisteine 375 mg - carbocisteine - carbocisteine - treatment of disorders of the respiratory tract characterised by excessive or viscous mucus.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

crop culture pty ltd - clopyralid present as the potassium salt - water soluble granules - clopyralid present as the potassium salt pyridine active 750.0 g/kg - herbicide

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

apvma permit - paclobutrazol(250g/l) - pgr

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - modafinil, quantity: 100 mg - tablet - excipient ingredients: magnesium stearate; colloidal anhydrous silica; croscarmellose sodium; methylcellulose - modafinil is indicated: ? to improve wakefulness in patients with excessive daytime sleepiness associated with narcolepsy; ? to treat excessive sleepiness associated with moderate to severe chronic shift work sleep disorder where nonpharmacological interventions are unsuccessful or inappropriate; ? as an adjunct to continuous positive airways pressure (cpap) in obstructive sleep apnoea/hypopnoea syndrome in order to improve wakefulness.

Australia - English - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - armodafinil, quantity: 50 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; povidone; magnesium stearate; pregelatinised maize starch; croscarmellose sodium; microcrystalline cellulose - ?to improve wakefulness in patients with excessive daytime sleepiness associated with narcolepsy,?to treat excessive sleepiness associated with moderate to severe chronic shift work sleep disorder where nonpharmacological interventions are unsuccessful or inappropriate,?as an adjunct to continuous positive airways pressure (cpap) in obstructive sleep apnoea/hypopnoea syndrome in order to improve wakefulness.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - modafinil, quantity: 100 mg - tablet, uncoated - excipient ingredients: povidone; aluminium magnesium silicate; lactose monohydrate; purified talc; maize starch; croscarmellose sodium; magnesium stearate - modafinil is indicated:,? to improve wakefulness in patients with excessive daytime sleepiness associated with narcolepsy;,? to treat excessive sleepiness associated with moderate to severe chronic shift work sleep disorder where nonpharmacological interventions are unsuccessful or inappropriate;,? as an adjunct to continuous positive airways pressure (cpap) in obstructive sleep apnoea/hypopnoea syndrome in order to improve wakefulness.